限制性股票激励计划
Search documents
江苏华海诚科新材料股份有限公司 关于向2024年限制性股票激励计划激励对象授予预留限制性股票的公告
Zhong Guo Zheng Quan Bao - Zhong Zheng Wang· 2025-09-27 00:38
Core Viewpoint - Jiangsu Huahai Chengke New Materials Co., Ltd. has approved the grant of reserved restricted stocks under the 2024 restricted stock incentive plan, with a total of 99,000 shares to be granted at a price of 25.77 yuan per share on September 26, 2025 [2][6][22]. Group 1: Restricted Stock Grant Details - The reserved restricted stock grant date is set for September 26, 2025 [2]. - A total of 99,000 shares will be granted to 8 eligible incentive objects [2][9]. - The grant price for the restricted stocks is 25.77 yuan per share [2][22]. Group 2: Decision-Making Process and Disclosure - The decision-making process for the incentive plan has been completed, including approvals from the board and supervisory committee [3][5]. - The company disclosed the incentive plan and related documents on the Shanghai Stock Exchange website [3][4][5]. - The names and positions of the proposed incentive objects were publicly announced internally, with no objections received [4][28]. Group 3: Compliance with Grant Conditions - The board confirmed that all conditions for granting the restricted stocks have been met, including compliance with relevant laws and regulations [6][7][22]. - The incentive objects have not been disqualified under any applicable regulations [7][8]. Group 4: Financial Impact of the Incentive Plan - The total estimated expense for the stock grants is approximately 8.2631 million yuan, which will be amortized over the vesting period [15][21]. - The accounting treatment for the restricted stocks will follow the relevant accounting standards, impacting the company's financial statements [15][18]. Group 5: Legal Opinions and Compliance - Legal opinions confirm that the adjustments and grants have received necessary approvals and comply with relevant regulations [23][34][46]. - The company has fulfilled its disclosure obligations as required by law [24][34][46].
易点天下网络科技股份有限公司 2025年限制性股票激励计划预留授予 激励对象名单(预留授予日)
Zheng Quan Ri Bao· 2025-09-26 23:44
一、 激励对象获授的限制性股票分配情况 本次激励计划预留部分拟授予的限制性股票在各激励对象间分配情况如下表所示: 登录新浪财经APP 搜索【信披】查看更多考评等级 注:1、上述任何一名激励对象通过全部在有效期内的股权激励计划获授的本公司股票均未超过公司总 股本的1%。公司全部有效期内的激励计划所涉及的标的股票总数累计不超过股权激励计划提交股东大 会审议时公司股本总额的20%。 2、本激励计划拟授予的激励对象不包括单独或合计持有公司5%以上股份的股东或实际控制人及其配 偶、父母、子女。 3、预留部分的激励对象由本激励计划经股东大会审议通过后12个月内确定,经董事会提出、薪酬与考 核委员会发表明确意见、律师发表专业意见并出具法律意见书后,公司在指定网站按要求及时披露激励 对象相关信息。 4、上表中数值若出现总数与各分项数值之和尾数不符,均为四舍五入原因所致。 易点天下网络科技股份有限公司 董事会 2025年9月27日 证券代码:301171 证券简称:易点天下 公告编号:2025-073 易点天下网络科技股份有限公司 关于全资孙公司出售参股企业股权 暨关联交易的公告 本公司及董事会全体成员保证信息披露的内容真实、 ...
三生国健药业(上海)股份有限公司关于2024年限制性股票激励计划首次授予部分第一个归属期符合归属条件的公告
Shang Hai Zheng Quan Bao· 2025-09-26 18:32
登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码:688336 证券简称:三生国健公告编号:2025-055 三生国健药业(上海)股份有限公司 关于2024年限制性股票激励计划 首次授予部分第一个归属期符合 归属条件的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏,并对其内容 的真实性、准确性和完整性依法承担法律责任。 重要内容提示: ● 限制性股票拟归属数量:134.301万股 5、归属安排具体如下: 本次激励计划首次授予的限制性股票的归属安排如下表所示: ■ ● 归属股票来源:公司向激励对象定向发行的公司A股普通股 三生国健药业(上海)股份有限公司(以下简称"公司")于2025年9月26日召开第五届董事会第十二次 会议,审议通过了《关于2024年限制性股票激励计划首次授予部分第一个归属期符合归属条件的议 案》。公司2024年限制性股票激励计划(以下简称"本次激励计划")首次授予部分第一个归属期符合归 属条件。现将有关事项说明如下: 一、本次激励计划批准及实施情况 (一)本次激励计划的主要内容 1、股权激励方式:第二类限制性股票。 2、授予数量:根据《三生国健 ...
厦门吉宏科技股份有限公司关于2023年限制性股票激励计划部分限制性股票回购注销完成的公告
Shang Hai Zheng Quan Bao· 2025-09-26 18:18
Core Viewpoint - The company has completed the repurchase and cancellation of 2,274,000 restricted stocks from its 2023 incentive plan due to unmet performance targets and the departure of certain incentive recipients [2][11][12]. Summary by Sections Repurchase and Cancellation Details - The repurchased stocks represent 0.5910% of the company's total A-share capital before the repurchase, which was 384,769,288 shares [2][13]. - The repurchase price was set at 8.8120 CNY per share, totaling 20,038,488 CNY funded by the company's own resources [2][15]. - Following the cancellation, the total A-share capital will decrease to 382,495,288 shares [2][16]. Reasons for Repurchase - The repurchase was necessitated by the failure to meet the performance assessment criteria for the 2024 fiscal year, where the net profit from the cross-border e-commerce business dropped by 68.87% compared to 2022, failing to meet the required growth rate of 21% [11]. - Additionally, seven incentive recipients left the company, leading to the cancellation of their stock options [11][12]. Approval Process - The company held multiple board and shareholder meetings to approve the repurchase and related amendments to its articles of association [3][6][10]. - Legal opinions were provided by Beijing Kangda Law Firm regarding the repurchase and its compliance with relevant laws [10][11]. Impact on Company Structure - After the repurchase, the number of unvested restricted stocks will be reduced from 4,134,000 to 1,860,000 [16]. - The company asserts that this action will not adversely affect its financial status or operational results, nor will it harm the interests of the company and its shareholders [16]. Future Actions - The company will proceed with the necessary legal and regulatory filings to update its registered capital and amend its articles of association following the completion of the stock repurchase [16].
上海皓元医药股份有限公司第四届董事会第十二次会议决议公告
Shang Hai Zheng Quan Bao· 2025-09-26 18:15
Core Viewpoint - The company has announced adjustments to the grant prices of its restricted stock incentive plans for 2023 and 2025, reflecting changes due to upcoming dividend distributions and compliance with relevant regulations [11][29]. Group 1: Board Meeting and Resolutions - The fourth board meeting was held on September 26, 2025, with all seven directors present, confirming the legality and validity of the meeting [1][2]. - The board approved the adjustment of the grant price for the 2023 restricted stock incentive plan from 22.56 CNY/share to 22.48 CNY/share [11][27]. - The board also approved the adjustment of the grant price for the 2025 restricted stock incentive plan from 21.62 CNY/share to 21.39 CNY/share [5][28]. Group 2: Adjustment Reasons and Methods - The adjustments were made in light of the company's 2024 annual dividend distribution and the upcoming 2025 semi-annual dividend distribution [25][26]. - The adjustment method for the 2023 plan involved reducing the grant price by the amount of cash dividends distributed, resulting in a new price of 22.48 CNY/share [27]. - Similarly, the adjustment for the 2025 plan was calculated using the same method, leading to a new grant price of 21.39 CNY/share [28]. Group 3: Compliance and Legal Opinions - The adjustments have been reviewed and approved by the board's remuneration and assessment committee, ensuring compliance with relevant laws and regulations [30][31]. - Legal opinions from Shanghai Guangfa Law Firm and DeHeng Law Firm confirmed the legality and validity of the adjustments for both incentive plans [32][34].
通宇通讯拟回购注销44.69万股限制性股票 注册资本将相应减少44.69万元
Xin Lang Cai Jing· 2025-09-26 12:40
Group 1 - The company held its 27th meeting of the 5th Board of Directors on September 26, 2025, to review the proposal regarding the repurchase and cancellation of certain restricted stocks due to unmet performance targets [1] - The company decided to repurchase and cancel 446,875 shares of restricted stock granted to 70 incentive recipients, as the performance assessment criteria for the second unlock period were not achieved [1] - Following the repurchase and cancellation, the company's total share capital will decrease by 446,875 shares, and the registered capital will also be reduced by 446,875 yuan [1] Group 2 - Creditors have the right to request the company to settle debts or provide guarantees within 45 days from the announcement of the repurchase and cancellation due to the reduction in registered capital [1] - If creditors do not declare their claims within the specified period, their claims remain valid, and the company will continue to fulfill its obligations according to the original debt documents [1] - Creditors must submit a written request along with relevant proof documents to the company if they seek debt settlement or guarantees [1]
壹连科技:拟推182.83万股限制性股票激励计划
Ge Long Hui· 2025-09-26 12:35
格隆汇9月26日丨壹连科技(301631.SZ)公布2025年限制性股票激励计划,本激励计划拟授予的限制性股 票数量为182.83万股,约占本激励计划草案公告时公司股本总额的2.00%。本激励计划首次授予限制性 股票的激励对象共计215人,本激励计划限制性股票首次及预留授予价格为49.93元/股。 ...
康希诺(688185.SH)拟推258万股A股限制性股票激励计划
智通财经网· 2025-09-26 11:58
智通财经APP讯,康希诺(688185.SH)披露2025年A股限制性股票激励计划(草案),拟向激励对象授予258 万股限制性股票,约占2025年A股激励计划草案公告时公司股本总额的1.04%。其中首次授予206.55万 股,首次授予的激励对象人数共计87人,授予价格(含预留)为41.20元/股。 ...
华海诚科授予9.90万股限制性股票
Ju Chao Zi Xun· 2025-09-26 11:49
Core Viewpoint - Huahai Chengke (688535.SH) announced the approval of a restricted stock incentive plan aimed at enhancing employee engagement and driving sustainable growth [1][3] Group 1: Incentive Plan Details - The board approved the grant of a total of 99,000 restricted stocks to 8 eligible participants at a price of 25.77 yuan per share, with the grant date set for September 26, 2025 [3] - The incentive plan is expected to improve the long-term incentive mechanism of the company, fostering a sense of belonging and motivation among core employees [3] Group 2: Financial Performance and Market Position - In the first half of 2025, Huahai Chengke achieved steady growth in both revenue and net profit, further solidifying its market position in the semiconductor chip packaging materials sector [3] - The company plans to continue attracting and retaining talent through stock incentives, aiming to enhance its core competitiveness and drive the industrial application of innovative results [3]
永创智能拟推292.8万股第二期限制性股票激励计划
Zhi Tong Cai Jing· 2025-09-26 11:21
Group 1 - The core point of the article is that Yongchuang Intelligent (603901.SH) has disclosed its second phase of the restricted stock incentive plan for 2025, proposing to grant 2.928 million shares to incentive targets, which accounts for approximately 0.60% of the company's total share capital at the time of the announcement of the plan [1] - The grant will be a one-time award with no reserved portion [1] - A total of 42 individuals will be granted the shares at a price of 5.68 yuan per share [1]